Dr. Steven M. Larson

Internal Medicine
Memorial Sloan Kettering Cancer Center
1275 York Ave, 
New York, NY 
Memorial Sloan Kettering Cancer Center
1275 York Ave, 
New York, NY 

Overview

Steven Larson is a primary care provider, practicing in Internal Medicine in New York, New York.

His clinical expertise encompasses Lung Cancer, Peripheral T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, and EGFR Positive Lung Cancer.

He is actively involved in clinical research, participating in 5 clinical trials.

Specialties

Internal Medicine

Licenses

Nuclear Medicine in NY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Memorial Sloan Kettering Cancer Center
1275 York Ave, New York, NY 10065

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Pilot Trial To Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
Pilot Trial To Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2026
Intervention Type: Drug
Study Phase: Not Applicable
A Pilot Study of Radioimmunodetection of 124-Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients With Colorectal Cancer
A Pilot Study of Radioimmunodetection of 124-Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients With Colorectal Cancer
Enrollment Status: Completed
Publish Date: July 04, 2025
Intervention Type: Drug
Study Phase: Not Applicable
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
39
conditions
Dr. Mark G. Lebwohl
Internal Medicine
Expertise in
39
conditions
Dr. Mark G. Lebwohl
Internal Medicine
Before you request

Icahn School Of Medicine At Mount Sinai

5 E 98th St, 
New York, NY 
 (1.7 miles away)
212-241-9728
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Lebwohl is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Lebwohl is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Plaque Psoriasis, Psoriasis, Pustular Psoriasis, and Generalized Pustular Psoriasis (GPP). Dr. Lebwohl is currently accepting new patients.

Expertise in
13
conditions
Dr. Ryan C. Ungaro
Internal Medicine
Expertise in
13
conditions
Dr. Ryan C. Ungaro
Internal Medicine

MSSM-Optical Shop

17 E 102nd St, 
New York, NY 
 (1.9 miles away)
212-241-8100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ryan Ungaro is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Ungaro is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Colonoscopy, and Endoscopy.

Expertise in
14
conditions
Dr. John P. Bilezikian
Internal Medicine
Expertise in
14
conditions
Dr. John P. Bilezikian
Internal Medicine
Before you request

NewYork Presbyterian Columbia University Irving Medical Center

180 Fort Washington Ave, 
New York, NY 
 (5.3 miles away)
212-305-2663
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Bilezikian is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Bilezikian is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Hypoparathyroidism, Hypercalcemia, Milk-Alkali Syndrome, Parathyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Bilezikian is currently accepting new patients.

Frequently Asked Questions about Dr. Steven M. Larson

How do I make an appointment with Dr. Steven M. Larson?

You can book an appointment with Dr. Steven M. Larson by calling their office at 212-639-7373. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Steven M. Larson a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Steven M. Larson is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Steven M. Larson specialize in?

While Dr. Steven M. Larson is a Internal Medicine, they have specific expertise in Lung Cancer, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Steven M. Larson accept my insurance?

Dr. Steven M. Larson accepts most major insurance plans, including UnitedHealthcare. We recommend calling the office directly at 212-639-7373 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Larson's expertise for a condition
ConditionClose
        View All 22 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile